Joe Hermosilla Jara

Joe Hermosilla Jara

Auto-generated profile, based on publicly available information

Joe Hermosilla Jara

Laboratorio de Virología Clínica y Molecular. Universidad Nacional Mayor de San Marcos, Lima, Perú

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 June 2015 in Revista de Investigaciones Veterinarias del Perú
Verified
Journal Article
Open access
PDF file
AIAsucena Naupay I.
Asucena Naupay I.
JHJulia Castro H.
Julia Castro H.
JCJunior Caro C.
Junior Caro C.
LDLucas Sevilla D.
Lucas Sevilla D.
JJJoe Hermosilla J.
Joe Hermosilla J.
OROscar Panana R.
Oscar Panana R.
El objetivo del presente trabajo fue determinar la prevalencia, intensidad media y abundancia media de ectoparásitos en palomas domésticas (Columba livia) comercializadas en un mercado de la ciudad de Lima, Perú. Se analizaron 29 ejemplares (17 machos y 12 hembras). Se inspeccionó la superficie externa de la cabeza, cuello, pecho, dorso y alas, determinando que el 93.1% (14.9 ± 15.8 de abundancia media total) de las palomas estuvieron infestadas con uno o más ectoparásitos; asimismo, el 100 de los machos y 83.3% de las hembras estuvieron parasitados. Se identificaron siete especies de ectoparásitos, de los cuales cinco corresponden al Orden Mallophaga (Columbicola columbae [82.8%], Menopon gallinae [48.3%] Goniodes gigas [31%], Menacanthus stramineus [17.2%] y Lipeurus caponis [6.9%]), uno al Orden Diptera (Pseudolynchia canariensis [10.3%]), y uno al Orden Siphonapetra (Echidnophaga gallinacea [3.4%]). El mayor número de malófagos fue encontrado sobre las plumas de las alas y el pecho. En las asociaciones de parásitos, se encontró 28% de monoparasitismo, 28% de biparasitismo, 34% de triparasitismo y 3% de tetraparasitismo. C. columbae fue el ectoparásito con mayor prevalencia (82.8%). Además, se reporta por primera vez a Menacanthus stramineus y Lipeurus caponis como ectoparásitos de C. livia en el Perú.

25 June 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
BQBernardo Esteban Quispe-Bravo
Bernardo Esteban Quispe-Bravo
LDLucas Augusto Sevilla Drozdek
Lucas Augusto Sevilla Drozdek
JJJoe Hermosilla Jara
Joe Hermosilla Jara
IDIngrit Elida Collantes Díaz
Ingrit Elida Collantes Díaz
EDEdison Luiz Durigon
Edison Luiz Durigon
JHJuan Samuel Sulca Herencia
Juan Samuel Sulca Herencia
III. The Zika virus (ZIKV) of the Flaviviridae family is an emerging virus that caused, between 2016 and 2018, serious public health problems in Latin America, affecting neonates with greater severity. The clinical spectrum includes Guillain-Barré syndrome, microcephaly and others neurodegenerative diseases. There is no antiviral treatment or vaccine against this virus, for that reason the antiviral properties of various plants are being studied. Lippia alba , locally known as “Prontoalivio”, is an aromatic shrub of the Verbenaceae family with a wide geographical distribution (especially in South and Central America) and is used in traditional medicine against fever, skin diseases and as a pain reliever. In this study, the antiviral activity of the essential oil of Lippia alba against ZIKV was evaluated in the Vero 76 cell line. Lippia alba was collected in the department of Amazonas, in the rainforest of Peru, and identified in the Museo de Historia Natural of the Universidad Nacional Mayor de San Marcos. The essential oil sample was obtained by steam hydrodistillation. The essential oil showed cytotoxicity to a concentration greater than or equal to 167 μg/mL in the Vero 76 cell line. The antiviral activity of essential oil against ZIKV (previously identified by real-time PCR and propagated in the C6/36 cell line) was evaluated using the plaque reduction test (PRP). The essential oil showed antiviral activity in concentrations from 8.02 μg/mL to 20.88 μg/mL, which represents a range between 59.44% to 85.56% of plaque reduction and may be considered as a candidate for antiviral studies against ZIKV. IV. Author Summary: Environmental temperature fluctuations, human activities and vector characteristics increase ZIKV cases worldwide. This neglected disease has been silently affecting people of all ages, generating greater impact on neonates by causing microcephaly and other neurodegenerative diseases. ZIKV vaccines are in phase II trials and there is no antiviral treatment. Nowadays, the study of antiviral plants is gaining strength in the scientific community because they are known to contain chemical compounds that could be drugs candidates. In Peru, there are no antiviral treatments studies reported against Zika virus, this first report is important because it creates a new line of research for future studies of antiviral plant extracts against neglected viral-diseases. Finally, the essential oil of Lippia alba showed antiviral activity against ZIKV in Vero 76 cells, moreover, we intend to carefully isolate and study the chemical compounds as drug candidates in animals trials and possible humans trials. Disclaimer: The views expressed in this manuscript are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, nor the U.S. Government. Copyright statement: Juan Sulca is an employee of the U.S. Government. This work was prepared as part of their official duties. Title 17 U.S.C. § 105 provides that ‘Copyright protection under this title is not available for any work of the United States Government’. Title 17 U.S.C. § 101 defines a U.S. Government work as a work prepared by a military service member or employee of the U.S. Government as part of that person’s official duties.

30 June 2023 in ACTA MEDICA PERUANA
Verified
Journal Article
Open access
PDF file
LDLucas Augusto Sevilla Drozdek
Lucas Augusto Sevilla Drozdek
EHEgma Mayta Huatuco
Egma Mayta Huatuco
EMEnrique Walter Mamani
Enrique Walter Mamani
NPNora Reyes Puma
Nora Reyes Puma
KCKarla Vásquez Cajachahua
Karla Vásquez Cajachahua
JHJuan Sulca Herencia
Juan Sulca Herencia
Objective: Adapt the microneutralization test (MNT) to detect neutralizing antibodies against dengue serotype 2 virus (DENV-2) in the Vero-76 cell line.  Materials and methods. Different cellular concentrations (0.6 x 105 cell / mL, 0.9 x 105 cell / mL, 1.2 x 105 cell / mL) and percentages of fetal bovine serum (FBS) at 2%, 3% and 4%, passages number of virus stock and incubation days were evaluated. The viral seed was confirmed by RT-qPCR. DENV-2 was propagated by carrying out 5 successive passages in the Vero-76 cell line, then the virus was titrated in microplates and 2 methods were evaluated: complete monolayer and cell suspension, and the optimal coloring day was determined. Obtained the results, it was evaluated by the MNT for DENV-2: 5 sera negative to DENV-2 and YFV, 5 sera negative to DENV-2 and seropositive to YFV and 5 seropositive sera to DENV-2 confirmed by plaque reduction neutralization test. The samples were evaluated in triplicate and virus control and cell control were used. Results: The optimal method for MNT uses cells in suspension (0.9 x 105 cell / mL), 2% SBF and viral seed passage 5. The minimum dilution capable of differentiating a DENV-2 seropositive serum from a DENV-2 seronegative sera was 1:40, and the incubation time of the MNT for DENV-2 was 10 days. Conclusion: MNT allows the detection of IgG antibodies against DENV-2, provides reliable results and a greater number of samples can be analyzed with material savings.